Sunday, November 21, 2010

New York Jurors Find Merck Not Liable in Fosamax Bellwether Trial

Merck has won the second of three bellwether trials on Fosamax, Graves v. Merck & Co., 1:06-cv-05513 (S.D.N.Y.).  Judith Graves, a Florida resident, sued the company and alleged that Fosamax (an osteoporosis drug) caused her jawbone to deteriorate.  The jury asked the judge for the date of the first report from which Merck could have known of an association between Fosamax and jawbone problems and found that the report appeared six months after the plaintiff's problems started.  Accordingly, jurors might've decided that Merck couldn't have known about the risks in time to warn the plaintiff.

Merck faces more than 1,500 claims in federal and state courts alleging various defects in Fosamax.  So far it has won two of the three cases that have gone to a jury trial; the third awarded damages of $8 million to the plaintiff, which was reduced to $1.5 million.

The New York Times article on the trial is available here, and the Wall Street Journal article is available here.  TheStreet provides the most detailed coverage, which is available here.

ECB

http://lawprofessors.typepad.com/mass_tort_litigation/2010/11/new-york-jurors-find-merck-not-liable-in-fosamax-bellwether-trial.html

Pharmaceuticals - Misc., Procedure, Products Liability, Trial | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef0133f649c245970b

Listed below are links to weblogs that reference New York Jurors Find Merck Not Liable in Fosamax Bellwether Trial:

Comments

Post a comment